10 principais nurixtx.com concorrentes

aragen.com

Aragen Life Sciences offers reliable commercial API manufacturing services, ensuring high-quality production and scalability for pharmaceutical and biotech industries.

smmttx.com

Announcements, Financial Reports & Filings SEC Filings Reports

preludetx.com

Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines. Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline features highly selective KAT6A degraders and […]

fortressbiotech.com

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income.…

celcuity.com

Targeted therapies only work when inhibiting the target pathway disrupts the oncogenic process. Celcuity’s platform provides unparalleled insights into oncogenic pathways. We harness these insights to develop new targeted therapies for cancer patients. Our lead candidate is gedatolisib, a pan-PI3K, mTORC1/2 inhibitor that comprehensively blockades the PI3K/AKT/mTOR (PAM) pathway.

septerna.com

Careers - Septerna

moonlaketx.com

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company that provides next-level therapies to elevate care.

itftherapeutics.com

Explore the challenges patients face after FDA approval of treatments like DUVYZAT for Duchenne muscular dystrophy. Stephanie Trafton, Head of US Value & Access at ITF Therapeutics, discusses navigating insurance hurdles, available resources for securing access, and the supportive community dedicated to helping families overcome barriers to treatment. Discover vital support options and empowering insights to ensure you get the care you need.